Edwards Lifesciences (EW) Income Statement
Edwards Lifesciences Income Statement
Last quarter (Q2 2026), Edwards Lifesciences's total revenue was $1.74B, an increase of 13.63% from the same quarter last year. In Q2, Edwards Lifesciences's net income was $241.90M. See Edwards Lifesciences’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 6.07B | $ 5.44B | $ 5.01B | $ 5.38B | $ 5.23B | |
| $ 4.74B | $ 4.32B | $ 3.97B | $ 4.22B | $ 4.01B | |
| $ 3.10B | $ 2.94B | $ 2.55B | $ 2.51B | $ 2.40B | |
| Depreciation and Amortization | $ 156.60M | $ 155.20M | $ 144.90M | $ 139.60M | $ 134.80M |
| $ 1.43B | $ 1.72B | $ 1.53B | $ 1.93B | $ 1.86B | |
| $ 1.64B | $ 1.38B | $ 1.43B | $ 1.70B | $ 1.61B | |
| $ -363.30M | $ 169.40M | $ -54.90M | $ 65.00M | $ 91.60M | |
| $ 1.27B | $ 1.55B | $ 1.37B | $ 1.77B | $ 1.70B | |
| $ 1.07B | $ 4.17B | $ 1.40B | $ 1.52B | $ 1.50B | |
| Per Share Metrics | |||||
| Basic EPS | $ 1.84 | $ 6.98 | $ 2.31 | $ 2.46 | $ 2.41 |
| Diluted EPS | $ 1.83 | $ 6.97 | $ 2.30 | $ 2.44 | $ 2.38 |
| Weighted Average Shares Outstanding | 584.80M | 597.70M | 606.70M | 619.00M | 623.30M |
| Weighted Average Shares Outstanding (Diluted) | 585.80M | 599.30M | 609.40M | 624.20M | 631.20M |
Currency in USD
